يعرض 1,801 - 1,820 نتائج من 39,282 نتيجة بحث عن '(( significant ((disease increases) OR (nn decrease)) ) OR ( significant decrease decrease ))', وقت الاستعلام: 0.68s تنقيح النتائج
  1. 1801

    Data Sheet 2_Increasing Mu wave desynchronization after dance classes on people with Parkinson’s disease.pdf حسب Jade Thalia Rodrigues Vilhalva (20924084)

    منشور في 2025
    "…The results showed a statistically significant increase in Mu rhythm desynchronization in the alpha 1 band at the central channels after 6 months of dance classes. …"
  2. 1802
  3. 1803

    Correlation between HDI and EAPC. حسب Chengjun Hu (588206)

    منشور في 2025
    الموضوعات:
  4. 1804
  5. 1805
  6. 1806

    Global burden of disease dataset. حسب Manan Raina (14648477)

    منشور في 2025
    "…<div><p>Background</p><p>Chronic kidney disease (CKD) poses a significant global health challenge; however, its burden on pediatric populations remains underexplored. …"
  7. 1807
  8. 1808
  9. 1809
  10. 1810
  11. 1811
  12. 1812
  13. 1813
  14. 1814
  15. 1815
  16. 1816
  17. 1817

    Coronary heart disease framework diagram. حسب Xinyi Wei (2973381)

    منشور في 2025
    "…<div><p>Coronary heart disease (CHD) is a major cardiovascular disorder that poses significant threats to global health and is increasingly affecting younger populations. …"
  18. 1818

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
  19. 1819

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"
  20. 1820

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …"